Oppenheimer assumes coverage on Kempharm (NASDAQ: KMPH) with a Outperform rating and a price target of $13.00 (from $11.00).Analyst Derek ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE